Randomized Phase II Trial Induction Therapy for Early Stage Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Docetaxel|DRUG: Capecitabine
Sponsor: Emory University
Collaborators: Georgia Center for Oncology Research & Education|Sanofi